Literature DB >> 16171721

Significant left ventricular hypertrophy on SPECT imaging in a patient with hypertrophic cardiomyopathy: a comparative image with cardiac magnetic resonance.

Akash Ghai1, Evelyn Horn, Gregory Pearson, Sabahat Bokhari.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16171721     DOI： 10.1016/j.nuclcard.2005.05.011

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  8 in total

1.  American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983

2.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

3.  Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.

Authors:  R O Cannon; V Dilsizian; P T O'Gara; J E Udelson; W H Schenke; A Quyyumi; L Fananapazir; R O Bonow
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

4.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; N Sato; W C Roberts; J E Edwards; R S Chandra
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

5.  Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.

Authors:  V Dilsizian; R O Bonow; S E Epstein; L Fananapazir
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

6.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

Authors:  B J Maron; J S Gottdiener; S E Epstein
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

7.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

Authors:  James C C Moon; William J McKenna; Jane A McCrohon; Perry M Elliott; Gillian C Smith; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

8.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Lubna Choudhury; Heiko Mahrholdt; Anja Wagner; Kelly M Choi; Michael D Elliott; Francis J Klocke; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094
  8 in total
  2 in total

Review 1.  Left ventricular hypertrophy and SPECT myocardial perfusion imaging: finding the diamonds in the rough.

Authors:  Wael A Jaber; Frank P DiFilippo; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

2.  Poor tracking of myocardial walls and inaccurate estimation of systolic parameters in myocardial hypertrophy on gated myocardial perfusion SPECT resulted from erroneous placement of region of interest and contouring: A pitfall of commercially available software packages for cardiac analysis.

Authors:  Mohsen Qutbi; Yaser Shiravand; Mehdi Soltanshahi; Isa Neshandar Asli; Abdolhamid Bagheri
Journal:  J Nucl Cardiol       Date:  2018-07-13       Impact factor: 5.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.